Clinical Trial Update: A Dose-Finding Study of Tebapivat to Assess Efficacy, and Safety in Participants With Sickle Cell Disease (SCD) [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 dose-finding study to evaluate the efficacy and safety of tebapivat in participants with sickle cell disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• Tebapivat (tebapivat)

Snippet

Sponsor: Agios Pharmaceuticals, Inc. | Conditions: Sickle Cell Disease | Phase 2 | Status: ACTIVE_NOT_RECRUITING